Winton Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-142,500
| Closed | -$12.3M | – | 1371 |
|
|
2026
Q1 | $12.3M | Buy |
142,500
+37,149
| +35% | +$3.56M | 0.43% | 42 |
|
|
2025
Q4 | $10.1M | Buy |
+105,351
| New | +$10.2M | 0.35% | 72 |
|
|
2025
Q2 | – | Sell |
-45,066
| Closed | -$4.05M | – | 930 |
|
|
2025
Q1 | $4.05M | Buy |
45,066
+40,787
| +953% | +$3.65M | 0.25% | 98 |
|
|
2024
Q4 | $342K | Buy |
+4,279
| New | +$370K | 0.02% | 501 |
|
|
2024
Q2 | – | Sell |
-2,743
| Closed | -$239K | – | 672 |
|
|
2024
Q1 | $239K | Buy |
+2,743
| New | +$234K | 0.02% | 547 |
|
|
2023
Q3 | – | Sell |
-61,406
| Closed | -$5.41M | – | 872 |
|
|
2023
Q2 | $5.41M | Buy |
+61,406
| New | +$5.29M | 0.45% | 42 |
|
|
2022
Q3 | – | Sell |
-12,072
| Closed | -$1.08M | – | 1033 |
|
|
2022
Q2 | $1.08M | Sell |
12,072
-3,120
| -21% | -$316K | 0.06% | 459 |
|
|
2022
Q1 | $1.69M | Buy |
15,192
+6,620
| +77% | +$699K | 0.09% | 298 |
|
|
2021
Q4 | $887K | Sell |
8,572
-6,709
| -44% | -$777K | 0.05% | 505 |
|
|
2021
Q3 | $1.92M | Buy |
15,281
+8,454
| +124% | +$1.09M | 0.11% | 197 |
|
|
2021
Q2 | $847K | Sell |
6,827
-1,496
| -18% | -$188K | 0.05% | 619 |
|
|
2021
Q1 | $983K | Sell |
8,323
-907
| -10% | -$106K | 0.06% | 470 |
|
|
2020
Q4 | $1.08M | Buy |
9,230
+2,271
| +33% | +$250K | 0.08% | 363 |
|
|
2020
Q3 | $723K | Buy |
+6,959
| New | +$699K | 0.02% | 956 |
|
|
2020
Q1 | – | Sell |
-16,843
| Closed | -$1.91M | – | 1488 |
|
|
2019
Q4 | $1.91M | Sell |
16,843
-103,780
| -86% | -$11.4M | 0.03% | 816 |
|
|
2019
Q3 | $13.1M | Buy |
120,623
+106,481
| +753% | +$11.1M | 0.15% | 178 |
|
|
2019
Q2 | $1.38M | Buy |
14,142
+8,587
| +155% | +$784K | 0.03% | 343 |
|
|
2019
Q1 | $506K | Buy |
5,555
+2,450
| +79% | +$219K | 0.01% | 582 |
|
|
2018
Q4 | $282K | Buy |
3,105
+439
| +16% | +$41K | 0.01% | 684 |
|
|
2018
Q3 | $262K | Sell |
2,666
-97,080
| -97% | -$8.98M | 0.01% | 867 |
|
|
2018
Q2 | $8.54M | Buy |
99,746
+37,482
| +60% | +$3.13M | 0.22% | 181 |
|
|
2018
Q1 | $5M | Sell |
62,264
-14,900
| -19% | -$1.23M | 0.14% | 215 |
|
|
2017
Q4 | $6.23M | Buy |
77,164
+59,625
| +340% | +$4.78M | 0.18% | 163 |
|
|
2017
Q3 | $1.36M | Buy |
17,539
+661
| +4% | +$54.9K | 0.04% | 363 |
|
|
2017
Q2 | $1.5M | Buy |
16,878
+6,682
| +66% | +$563K | 0.04% | 296 |
|
|
2017
Q1 | $821K | Sell |
10,196
-2,727
| -21% | -$213K | 0.02% | 339 |
|
|
2016
Q4 | $921K | Buy |
12,923
+5,385
| +71% | +$423K | 0.03% | 329 |
|
|
2016
Q3 | $651K | Sell |
7,538
-108
| -1% | -$9.41K | 0.01% | 323 |
|
|
2016
Q2 | $663K | Sell |
7,646
-909
| -11% | -$73.5K | 0.01% | 285 |
|
|
2016
Q1 | $642K | Sell |
8,555
-118,543
| -93% | -$8.93M | 0.01% | 286 |
|
|
2015
Q4 | $9.78M | Sell |
127,098
-562,374
| -82% | -$42.3M | 0.09% | 247 |
|
|
2015
Q3 | $46.2M | Buy |
689,472
+443,642
| +180% | +$32.7M | 0.37% | 100 |
|
|
2015
Q2 | $18.2M | Sell |
245,830
-251,651
| -51% | -$19.2M | 0.17% | 211 |
|
|
2015
Q1 | $38.8M | Sell |
497,481
-18,913
| -4% | -$1.43M | 0.31% | 120 |
|
|
2014
Q4 | $37.3M | Sell |
516,394
-854,147
| -62% | -$59.3M | 0.46% | 59 |
|
|
2014
Q3 | $84.9M | Sell |
1,370,541
-440,122
| -24% | -$28M | 0.61% | 18 |
|
|
2014
Q2 | $115M | Buy |
+1,810,663
| New | +$110M | 0.79% | 4 |
|
Other funds holding MDT
MGP
Winton Group's MDT Position: Q2 2026 in Review
Winton Group sold out of Medtronic (MDT) in Q2 2026, closing a stake of 142,500 shares — an estimated $12.3M sold.
Winton Group first reported a position in MDT in Q2 2014 and held it in 37 quarters. The position peaked at $115M in Q2 2014. 1,395 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Winton Group reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
- Winton Group sold 142,500 Medtronic shares in Q2 2026, an estimated $12.3M.
- Winton Group first reported a position in Medtronic in Q2 2014 and held it in 37 quarters.
- Winton Group's Medtronic position peaked at $115M in Q2 2014.
- 1,395 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.